Cannon Financial Strategists, Inc. Abbott Laboratories Transaction History

Cannon Financial Strategists, Inc.

$572 Billion
Q3 2024

A detailed history of Cannon Financial Strategists, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cannon Financial Strategists, Inc. holds 4,361 shares of ABT stock, worth $505,570. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,361

Previous 4,061 7.39%

Holding current value

$505,570

Previous $447 Million 11.23%

% of portfolio

0.09%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $30,020 - $35,439	300 Added 7.39%	4,361 $497 Million
Q2 2024 Sep 10, 2024	BUY	$100.73 - $112.44 $439,283 - $490,350	4,361 New	4,361 $453 Million
Q1 2024 Oct 01, 2024	SELL	$109.52 - $120.96 $5.28 Million - $5.83 Million	-48,233 Reduced 91.71%	4,361 $496 Million
Q4 2023 Oct 18, 2024	SELL	$90.19 - $110.4 $27,057 - $33,120	-300 Reduced 6.88%	4,061 $447 Million
Q4 2023 Oct 01, 2024	BUY	$90.19 - $110.4 $4.35 Million - $5.32 Million	48,233 Added 1106.01%	52,594 $1.27 Billion
Q3 2023 Oct 18, 2024	BUY	$95.53 - $114.62 $4,298 - $5,157	45 Added 1.11%	4,106 $398 Million
Q3 2023 Oct 02, 2024	SELL	$95.53 - $114.62 $387,947 - $465,471	-4,061 Closed	0 $0
Q1 2023 Oct 02, 2024	SELL	$96.86 - $114.01 $29,058 - $34,203	-300 Reduced 6.88%	4,061 $411 Million
Q3 2022 Oct 18, 2024	SELL	$96.76 - $112.03 $18,190 - $21,061	-188 Reduced 4.42%	4,061 $393 Million
Q2 2022 Oct 18, 2024	BUY	$102.07 - $123.37 $10,309 - $12,460	101 Added 2.43%	4,249 $462 Million
Q1 2022 Oct 18, 2024	BUY	$114.02 - $139.04 $9,919 - $12,096	87 Added 2.14%	4,148 $491 Million
Q1 2021 Oct 02, 2024	BUY	$108.84 - $128.23 $441,999 - $520,742	4,061 New	4,061 $487 Million
Q4 2020 Oct 02, 2024	SELL	$105.0 - $114.42 $426,405 - $464,659	-4,061 Closed	0 $0
Q3 2020 Oct 02, 2024	SELL	$91.64 - $111.29 $27,492 - $33,387	-300 Reduced 6.88%	4,061 $442 Million
Q2 2020 Oct 18, 2024	SELL	$76.57 - $98.0 $8,575 - $10,976	-112 Reduced 2.68%	4,061 $371 Million
Q4 2019 Oct 18, 2024	BUY	$78.51 - $87.4 $8,793 - $9,788	112 Added 2.76%	4,173 $362 Million
Q4 2019 Oct 02, 2024	SELL	$78.51 - $87.4 $327,622 - $364,720	-4,173 Closed	0 $0
Q3 2019 Oct 02, 2024	BUY	$81.84 - $88.74 $9,166 - $9,938	112 Added 2.76%	4,173 $349 Million
Q1 2019 Oct 02, 2024	SELL	$66.22 - $80.06 $19,866 - $24,018	-300 Reduced 6.88%	4,061 $325 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.

Account

Cannon Financial Strategists, Inc. Abbott Laboratories Transaction History